ArticlePathology oncology research : POR2024

Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol.

Andrea Ceglédi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.